|
During the past few months, IQWiG has made several decisions public for recently reviewed drugs. For the first time, a body of evidence exists which can shed some light upon how restrictive and how timely access will be under the new AMNOG legislation regime in Germany.... Full Whitepaper » |
-
Breakthroughs in CRO Customer Service Register Now »
-
EU Product Launch – Key Considerations for Successful Niche and Orphan Drug Product Launches Register Now »
-
From Produce to Patients: Improving Efficiency, Accountability and Accessibility Through Use of GS1 Standards Watch Now »
-
Exploring Challenges and Opportunities in Predictive Safety Tools: Trends from Industry-Wide Surveys Watch Now »
-
Serialization 2/0 - Getting Prepared for the Future of Pharma Supply Chain Security Watch Now »
- Martyrs & Models: Early Returns from the AMNOG Era 2/6/2012
- The Impact of Globalisation on Ensuring Data Quality and Usability in Laboratory Informatics 2/3/2012
- The Virtual R&D Model 2012 and Beyond 2/2/2012
- Pharmaceutical Licensing Forecast: Exploring Innovative Business Development and Licensing Strategies 2/2/2012
- Pharma IQ Publish Big Pharma Global Recession Report - 44.4% Fear Redundancy in 2012 2/2/2012
- Cool Chain Excellence 2012 Awards Winners Announced! 1/31/2012
Pharmaceutical Licensing Forecast: Exploring Innovative Business Development and Licensing Strategies
Contributor: Pharma IQPosted: 2/2/2012
|
Signs suggest innovative business development and licensing strategies will continue to move from strength to strength as the industry adjusts to new dynamics and new business models. Full Article » |
Valea Video Series - Mechanics
Contributor:Posted: 1/10/2012
100 years of experience in intellectual property rights Valea’s vision is to be regarded as one of Europe’s leading consulting firms in the field of intellectual property rights, and to be the natural choice for companies that work proactively to optimise the return on their intangible assets. Full Video » |
The Impact of Globalisation on Ensuring Data Quality and Usability in Laboratory Informatics
Contributor: Andrea CharlesPosted: 2/3/2012
|
In this interview Eduard de Vries, Senior Manager IT Reference Laboratories & Asia-Pacific from IDEXX Laboratories discusses the impact globalisation has had on ensuring data quality and usability in laboratory informatics. De Vries also shares his insights on the pace of technological change and whether Pharma is ready. Full Podcast » |
Martyrs & Models: Early Returns from the AMNOG Era
Posted: 2/6/2012During the past few months, IQWiG has made several decisions public for recently reviewed drugs. For the first time, a body of evidence exists which can shed some light upon how restrictive and how timely access will be under the new AMNOG legislation regime in Germany. Full Whitepaper » |
-
Jahresforum End-to-End strategische Pharma Supply Chain
February 13-15, 2012,
Novotel Berlin Am Tiergarten -
6. Jahreskonferenz Pharma Packaging
February 13-15, 2012,
Radisson BLU Hotel -
Predictive Toxicology 2012
February 15-17, 2012,
London, UK
|
|
how to respect the safe storage of drugs in pharmaceutical storage enclosures? |
Posted by: marie | Answer this question
|
|
How "validation" of any protocol or instruements could be done? |
Posted by: deepalimane13@gmail.com | Answer this question
|
|
Hi What is the Job Profile of AREA BUSINESS MANAGER in PHARMA. |
Posted by: digvijay_singh24 | Answer this question
|
|
What is a current topic of discussion in the pharmaceutical industry that could have an impact on pharmaceutical companies? |
Posted by: charlottebooth06@hotmail.co.uk | Answer this question
|
|
What are the bases ( criteria ) to design and validate lyophilization cycle ? |
Posted by: essam.aljindy | Answer this question
|
|
how to respect the safe storage of drugs in pharmaceutical storage enclosures? |
Posted by: marie | Answer this question
Andrea Charles |
About Pharma IQ
Pharma IQ, a division of IQPC, is an international online community focusing on providing pharmaceutical and biotechnology professionals with knowledge, information and biotechnology articles. We are dedicated to creating a learning environment for sharing ideas, best practices and solutions within the pharmaceutical and biotech community.
|























Not a member? Sign Up
Reasons for Joining
Address your challenges through knowledge sharing with peers from our global network of specialists.
Benchmark your business initiatives with the who's who in the field.
Hear from industry pioneers how to maximize ROI in today's challenging economy.
And best of all It's FREE!